Peter E. Fecci

12.6k total citations · 3 hit papers
150 papers, 5.2k citations indexed

About

Peter E. Fecci is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Peter E. Fecci has authored 150 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 59 papers in Genetics and 54 papers in Immunology. Recurrent topics in Peter E. Fecci's work include Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (48 papers) and Immunotherapy and Immune Responses (35 papers). Peter E. Fecci is often cited by papers focused on Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (48 papers) and Immunotherapy and Immune Responses (35 papers). Peter E. Fecci collaborates with scholars based in United States, Canada and Japan. Peter E. Fecci's co-authors include John H. Sampson, Michael D. Gunn, Duane A. Mitchell, Pakawat Chongsathidkiet, David M. Ashley, Gary E. Archer, Darell D. Bigner, Karolina Woroniecka, Daniel Wilkinson and Glenn Dranoff and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Peter E. Fecci

141 papers receiving 5.2k citations

Hit Papers

Brain immunology and immunotherapy in brain tumours 2018 2026 2020 2023 2019 2018 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Fecci United States 38 2.4k 2.2k 2.1k 1.1k 1.1k 150 5.2k
Mahua Dey United States 29 1.5k 0.6× 1.5k 0.7× 1.3k 0.6× 467 0.4× 1.0k 0.9× 76 3.6k
John R. Ohlfest United States 36 1.7k 0.7× 1.5k 0.7× 891 0.4× 392 0.4× 1.5k 1.4× 65 4.2k
Hideho Okada United States 54 4.1k 1.7× 5.1k 2.4× 2.6k 1.3× 754 0.7× 2.8k 2.6× 198 8.8k
Jörg Wischhusen Germany 41 2.6k 1.1× 2.3k 1.0× 1.4k 0.7× 443 0.4× 2.7k 2.5× 91 6.7k
Juan Manuel Sepúlveda-Sánchez Spain 29 1.5k 0.6× 844 0.4× 1.7k 0.8× 723 0.6× 1.2k 1.1× 181 3.9k
Letterio S. Politi Italy 31 1.3k 0.5× 1.1k 0.5× 676 0.3× 548 0.5× 1.7k 1.6× 121 5.1k
John S. Yu United States 49 4.2k 1.7× 3.1k 1.5× 2.7k 1.3× 487 0.4× 3.3k 3.1× 171 8.7k
Chetan Bettegowda United States 43 1.7k 0.7× 795 0.4× 1.9k 0.9× 1.9k 1.7× 2.3k 2.1× 306 8.7k
Philipp Beckhove Germany 45 4.8k 2.0× 5.0k 2.3× 568 0.3× 709 0.6× 1.8k 1.7× 150 8.4k
Marc Schmitz Germany 46 2.8k 1.2× 3.2k 1.5× 851 0.4× 530 0.5× 2.0k 1.9× 173 6.4k

Countries citing papers authored by Peter E. Fecci

Since Specialization
Citations

This map shows the geographic impact of Peter E. Fecci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Fecci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Fecci more than expected).

Fields of papers citing papers by Peter E. Fecci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Fecci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Fecci. The network helps show where Peter E. Fecci may publish in the future.

Co-authorship network of co-authors of Peter E. Fecci

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Fecci. A scholar is included among the top collaborators of Peter E. Fecci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Fecci. Peter E. Fecci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotchkiss, Kelly, Sarah Cook, Ying Zhou, et al.. (2025). IL-7–mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models. Journal of Clinical Investigation. 135(12). 1 indexed citations
2.
Graham-Gurysh, Elizabeth G., Kathryn M. Moore, Christopher J. Genito, et al.. (2025). Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in mice. Nature Communications. 16(1). 8603–8603.
3.
Jackson, Joshua, Eric W. Sankey, Ethan Srinivasan, et al.. (2024). NIMG-05. ARTIFICIAL INTELLIGENCE-BASED RESPONSE ASSESSMENT FOR PATIENTS RECEIVING LASER INTERSTITIAL THERMAL THERAPY. Neuro-Oncology. 26(Supplement_8). viii195–viii195. 1 indexed citations
4.
Chiang, Veronica, Analiz Rodriguez, Sujit S. Prabhu, et al.. (2024). Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series. Journal of neurosurgery. 141(3). 642–652. 5 indexed citations
5.
Whiteley, Andrew E., Danhui Ma, Seok‐Yeong Yu, et al.. (2024). Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 384(6702). eadh5548–eadh5548. 38 indexed citations breakdown →
6.
Polania, Jessica Waibl, William H. Tomaszewski, Lucas P. Wachsmuth, et al.. (2024). Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 58(1). 232–246.e6. 36 indexed citations
7.
Srinivasan, Ethan, Yang Liu, Pakawat Chongsathidkiet, et al.. (2023). Gold Nanostars Obviate Limitations to Laser Interstitial Thermal Therapy (LITT) for the Treatment of Intracranial Tumors. Clinical Cancer Research. 29(16). 3214–3224. 6 indexed citations
8.
Otvos, Balint, Tyler Alban, Matthew M. Grabowski, et al.. (2021). Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome. Clinical Cancer Research. 27(7). 2038–2049. 23 indexed citations
9.
Tomaszewski, William H., Jessica Waibl Polania, Alexandra Miggelbrink, et al.. (2021). Broad immunophenotyping of the murine brain tumor microenvironment. Journal of Immunological Methods. 499. 113158–113158. 4 indexed citations
10.
Moravan, Michael J., Peter E. Fecci, Carey K. Anders, et al.. (2020). Current multidisciplinary management of brain metastases. Cancer. 126(7). 1390–1406. 72 indexed citations
11.
Woroniecka, Karolina, Kristen E. Rhodin, Cosette Dechant, et al.. (2019). 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers. Clinical Cancer Research. 26(6). 1349–1358. 38 indexed citations
12.
Huang, Min-Nung, Kristen A. Batich, Adam M. Swartz, et al.. (2019). Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses. Journal of Clinical Investigation. 130(2). 774–788. 48 indexed citations
13.
Riccione, Katherine A., Li-Zhen He, Peter E. Fecci, et al.. (2018). CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. OncoImmunology. 7(12). e1502904–e1502904. 10 indexed citations
14.
Truong, Tracy, Ali Zomorodi, Patrick J. Codd, et al.. (2018). Sinonasal Quality-of-Life Outcomes after Extended Endonasal Approaches to the Skull Base. Journal of Neurological Surgery Part B Skull Base. 79(S 01). S1–S188. 1 indexed citations
15.
Woroniecka, Karolina, Pakawat Chongsathidkiet, Aladine A. Elsamadicy, et al.. (2018). Flow Cytometric Identification of Tumor-Infiltrating Lymphocytes from Glioblastoma. Methods in molecular biology. 1741. 221–226. 10 indexed citations
16.
Farber, S. Harrison, Vadim Tsvankin, Grace J. Kim, et al.. (2016). Embracing rejection: Immunologic trends in brain metastasis. OncoImmunology. 5(7). e1172153–e1172153. 30 indexed citations
17.
Cheema, Tooba A., Peter E. Fecci, Jianfang Ning, & Samuel D. Rabkin. (2014). Immunovirotherapy for the treatment of glioblastoma. OncoImmunology. 3(1). e27218–e27218. 13 indexed citations
18.
Agarwalla, Pankaj K., Zachary R. Barnard, Peter E. Fecci, Glenn Dranoff, & William T. Curry. (2012). Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors. Journal of Immunotherapy. 35(5). 385–389. 95 indexed citations
19.
Fecci, Peter E., Hidenobu Ochiai, Duane A. Mitchell, et al.. (2007). Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function. Clinical Cancer Research. 13(7). 2158–2167. 265 indexed citations
20.
Moon, Paula F., Margaret Ramsay, Peter E. Fecci, & Peter W. Nathanielsz. (2001). Fetal exposure to magnesium chloride-adenosine triphosphate (MgCl2-ATP) results in alterations in cerebral blood flow and a metabolic acidosis. Pediatric Critical Care Medicine. 2(1). 74–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026